Fda Alerts Article Listing | RxWiki

FDA Alerts

Synribo for Chronic Myelogenous Leukemia Approved by FDA

The US Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

REFINE

medications
- - Remove Synribo filter (-) Remove Synribo filter Synribo
conditions
- - Remove Hematology filter (-) Remove Hematology filter Hematology
    Remove Blood Cancer filter (-) Remove Blood Cancer filter Blood Cancer
    Apply Leukemia filter Leukemia (1) Apply Leukemia filter
  - Apply Cancer filter Cancer (1) Apply Cancer filter